The Roundup

BioCT's weekly newsletter with the latest industry news, resources, and opportunities.

| By Lucy Rosenthal

The Roundup – September 19, 2024

    September 19, 2024 Welcome to BioCT’s Weekly Roundup! This week features a job opportunity at Yale Ventures and a SBIR workshop hosted by...

| By Lucy Rosenthal

The Roundup – September 12, 2024

    September 12, 2024 Welcome to BioCT’s Weekly Roundup! This week features news on member innovations, a professional development opportunity from FirstXFounder, and savings...

| By Lucy Rosenthal

The Roundup – September 5, 2024

    September 5, 2024 Welcome to BioCT’s Weekly Roundup! Here’s the latest life sciences news and upcoming events for your first week of fall....

| By Lucy Rosenthal

The Roundup – August 29, 2024

    August 29, 2024 Welcome to BioCT’s Weekly Roundup! Here’s the latest life sciences news and upcoming events for your final week of summer....

| By Lucy Rosenthal

The Roundup – August 22, 2024

    August 22, 2024 Member News Astrocyte Pharmaceuticals named “Innovator of the Month” by Senator Chris Murphy BIO News: Pediatric Priority Review Voucher reauthorization introduced in...

| By Lucy Rosenthal

The Roundup – August 8, 2024

    August 8, 2024 Member News AbbVie completes acquisition of Cerevel Therapeutics Aon – H1 2024 credit solutions market insights report: better decisions for...

| By Kelley Gipson

The Roundup – July 25, 2024

July 25, 2024 Member News Aspira Women’s Health announces closing of $1.9 million private placement equity financing AstraZeneca signs preclinical EGFR drug deal with antibody...

| By Kelley Gipson

The Roundup – May 2, 2024

May 2, 2024 BioCT News Boehringer Ingelheim ‘Office Hours’ program returns to mentor 4 companies Bioscience industry: Prescription drug safety net program is failing patients in...

| By Kelley Gipson

The Roundup – April 25, 2024

View this email in your browser April 25, 2024 Member News AbbVie, NeuroDerm heat up Levodopa competition with new data at AAN24 AbbVie tops doctor ranking...

| By Kelley Gipson

The Roundup – April 18, 2024

View this email in your browser April 18, 2024 Member News AbbVie announces late-breaking data at AAN supporting long-term safety and efficacy of Atogepant (QULIPTA®) for...